Tildrakizumab Delivers Long-Term Control in Hard-to-Treat Psoriasis Areas
AJMC reports tildrakizumab sustained long-term psoriasis control in hard-to-treat areas such as scalp, palms and soles, strengthening the IL-23 case.
Topic
Tildrakizumab
Topic
Topic
Topic
AJMC reports tildrakizumab sustained long-term psoriasis control in hard-to-treat areas such as scalp, palms and soles, strengthening the IL-23 case.